Skip to content

CYPH CYPH Deferred Offering Costs Included In Accounts Payable

Deferred Offering Costs Included In Accounts Payable at other companies

SIM
Sonics & Materials, Inc.SIMA
$5K
Candel Therapeutics, Inc. logo
Candel Therapeutics, Inc.CADL
$23.25K
NetSTREIT logo
NetSTREITNTST
$502K+1,992%
Omada Health, Inc. Common Stock logo
Omada Health, Inc. Common StockOMDA
$0-100%
Schering-Plough logo
Schering-PloughSGP
$17K
ORI
Origin Investment Corp I Ordinary SharesORIQ
$87.95K

Other financials

Income statement

See full
Revenue$375.0K
Operating income-$4.8M+69.7%
Net income-$77.2M-400%
EPS (diluted)-$0.46-24.3%

Balance sheet

See full
Cash & equivalents$6.7M-79.6%
Total debt$38.0K-75.3%
Total equity$84.4M+305%
Total assets$87.4M+151%

Cash flow

See full
Operating cash flow-$3.4M+76.3%

Valuation

See full
Market cap$65.19M-54.5%
Enterprise value$58.54M
P/S43.5×

Profitability

See full
Operating margin-2,761.7%
Net margin-2,705.8%

Returns & leverage

See full
Return on equity-108.2%-34.4pp
Debt / equity0.0×
Current ratio27.3×+24.9×

Where this comes from

Reported directly by CYPH in its filing.

Tagged under the XBRL concept cyph:DeferredOfferingCostsIncludedInAccountsPayable.

The official record: CYPH’s 10-K, filed March 16, 2026, on SEC EDGAR. View the filing →

Ask your AI about CYPH's deferred offering costs included in accounts payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CYPH's deferred offering costs included in accounts payable?
CYPH (CYPH) reported deferred offering costs included in accounts payable of $159.5K in Q4 2025.
What does deferred offering costs included in accounts payable mean?
This metric captures costs related to equity or debt offerings that have been incurred but not yet paid, and are currently recorded as accounts payable. These costs are typically deferred and subsequently amortized or offset against the proceeds of the offering. Tracking this figure provides insight into the company's pending capital raising expenses and short-term liabilities associated with financing activities.